|
COMMERCE BUSINESS DAILY ISSUE OF AUGUST 2,1995 PSA#1401DHHS/PHS/FDA/Office of Facilities, Acquisition and Central Services,
Contracts Operations Branch, HFA-512, 5600 Fishers Lane, Park Building,
Room 3-32, Rockville, MD 20857 A -- USE OF HUMAN FLORA-ASSOCIATED RODENTS TO STUDY THE EFFECT OF LOW
DOSES OF ANTIMICROBIALS SOL 223-96-7093 DUE 091895 POC Harriet
Lilienfeld, Contract Specialist, (301) 443-4420, M. Deborah
Smith-Castle, Contracting Officer, (301) 443-0424 The Center for
Veterinary Medicine of the Food and Drug Administration has a
requirement for a 3-year study to determine the concentration of
selected antimicrobials (ampicillin, neomycin, and tetracycline) that
produces no adverse effect in the human flora-associated rodent model.
Adverse effects to be evaluated are: 1) changes in metabolic activity
of fecal flora relating to metabolism of endogenous and exogenous
compounds; 2) development of antimicrobial resistant strains; 3)
disruption of colonization resistance to pathogenic microorganisms; and
4) counts of target organisms. The fecal suspension used to inoculate
the rodents will originate from healthy volunteer(s) not treated with
antibiotics for at least 3 months. (0212) Loren Data Corp. http://www.ld.com (SYN# 0003 19950801\A-0003.SOL)
A - Research and Development Index Page
|
|